I've told you about coming around the corner with "personalized medicine" before. Now, here's seven stocks to research on your own that could be big-time winners...

One of my premium recommendations has delivered mega-gains to subscribers, but I still see some upside from here. Learn more...

If you sold during the December dip, you're probably kicking yourself. But has the dust cleared? Here's why I'm staying focused on the strongest corner of the market instead of worrying...

Was the snap-back rally enough to restore trust in the market? It should be. Especially if you have a strong-enough plan in the first place...

Two huge deals in the cancer treatment space could be a sign of more things to come. Here's what you need to know...

I'm always on the hunt for growth -- and the world of small-cap stocks is always fertile hunting ground. Here are five I've got my eye on right now...

Peter Lynch is probably the greatest mutual fund manager of all time. Here's what he had to say about successful investing...

Instead of thinking about how many times you were right with your stock picks, it's time to start thinking about what really matters: how much money you're making.

New technology is giving doctors is the ability to treat patients with drugs tailored at the molecular level. The implications of this are huge -- here's how I'm planning to invest...

A $74 billion deal will create a biotech powerhouse. But is this a good deal? And is it worth owning today?